Suchen und Finden

Titel

Autor

Inhaltsverzeichnis

Nur ebooks mit Firmenlizenz anzeigen:

 

Clinician's Guide to ADHD Comorbidities in Children and Adolescents - Case Studies

Clinician's Guide to ADHD Comorbidities in Children and Adolescents - Case Studies

Joseph Sadek

 

Verlag Springer-Verlag, 2018

ISBN 9783319456355 , 148 Seiten

Format PDF, OL

Kopierschutz Wasserzeichen

Geräte

64,19 EUR

Mehr zum Inhalt

Clinician's Guide to ADHD Comorbidities in Children and Adolescents - Case Studies


 

Foreword

6

Contents

8

About the Author and Reviewers

15

Introduction

18

1: ADHD and Epilepsy

19

1.1 Objectives

19

1.2 The Case

19

1.2.1 Emerson English

20

1.2.2 Questions

21

References

24

2: ADHD and Borderline Personality Disorder (BPD) in Adolescence

26

2.1 Objectives

26

2.2 The Case

26

2.3 Barbara B

27

2.3.1 History of Present Illness and Review of Systems

27

2.3.1.1 Collateral History

28

2.3.2 Summary of the Findings and Management of This Patient

29

2.4 Literature Review Questions

29

2.4.1 Discuss the Challenges Around the Diagnosis of Borderline Personality Disorder (BPD) in Adolescents?

29

2.4.2 Discuss the Epidemiology and Comorbidity of ADHD and Borderline Personality Disorder (BPD)?

30

2.4.3 List Some of the Different Hypothesis That Are Proposed to Account for the Comorbidity Between ADHD and BPD?

31

2.4.4 What Are the Diagnostic Symptoms Criteria of Borderline Personality Disorder?

31

2.4.5 What Are Some of the Warning Signs That May Point to Presence of BPD in Adolescence?

32

2.4.6 Describe Some of the Key Similarities and Differences Between Borderline Personality Disorder and ADHD?

32

2.4.7 What Are the Management Difficulties in Patients with Comorbid ADHD and BPD That Are Related to BPD?

32

2.4.8 Why Is It Important to Recognize a Comorbid Personality Disorder in Patients with ADHD?

33

2.4.9 What Are the Potential Advantages of a Dimensional Model over a Categorical Model in Diagnosing BPD?

33

2.4.10 What Are Some of the Helpful Tips for Managing Borderline Patients in Primary Care Setting?

33

2.4.11 What Are the Key Clinical Treatment Recommendations in Patients with BPD and ADHD?

34

2.4.12 Give Examples of Psychotherapeutic Approaches for Patients with BPD?

34

2.4.13 Is There Any Evidence for Mindfulness Based Interventions in ADHD and BPD?

35

2.4.14 What Is the General Approach to Pharmacotherapy for BPD?

35

2.4.15 What Are the Literature Recommendations for Pharmacological Therapy for Patients with ADHD and BPD?

36

References

36

3: ADHD and Anxiety

39

3.1 Objectives

39

3.2 The Case

39

3.2.1 Amanda Austin

39

3.2.2 History of Present Illness

39

3.2.2.1 Medical History

40

3.2.2.2 Family History

40

3.2.2.3 Personal and Developmental History

40

3.2.2.4 Case Outcome

41

3.3 Literature Review Questions on ADHD and Anxiety

41

3.3.1 Describe the Prevalence Rates and Epidemiological Data of ADHD and Anxiety?

41

3.3.2 What Are the Overlapping and Differentiating Symptoms Between ADHD and Anxiety?

41

3.3.3 Describe Some of the Difficulties in Conducting Meta-Analysis on the Effect of Stimulant Medications on Comorbid Anxiety in ADHD Patients in the Current Literature?

42

3.3.4 List Some of the Instruments That Would Assist Clinicians in Identifying Different Anxiety Disorders?

42

3.3.5 What Is the Role of Parental Anxiety in Patients with ADHD and Anxiety?

43

3.3.6 Describe Some of the Literature Findings on the Relationship Between Trauma and ADHD?

43

3.3.7 What Are the Treatment Considerations in Comorbid ADHD and Anxiety Disorders?

44

3.3.8 What Are the Dosing Recommendations for Atomexetine (ATX) in Children and Adolescents?

45

3.3.9 What Are the Specific Tapering Recommendations to Stop Atomoxetine and What Are the Withdrawal Symptoms?

45

3.3.10 What Are the Dosing Reduction Requirements in Adolescents with Hepatic Impairment When Prescribing Atomoxetine?

45

3.3.11 Does the Literature Recommends Fast Dose Titration or Slow Dose Titration When Starting Atomoxetine?

45

References

46

4: ADHD and Obesity

48

4.1 Objectives

48

4.2 ADHD and Obesity Literature Review Questions

48

4.2.1 Describe the Possible Relationship Between ADHD and Obesity?

48

4.2.2 What Are Some of the Different Hypothesis That May Explain the Association Between ADHD and Obesity?

49

4.2.3 What Is the Impact of ADHD on Weight Loss Effort?

49

4.2.4 What Are the Principals of Management of Adolescent Patients with ADHD and Obesity?

49

4.2.5 Describe Some of the Research Findings of the Mental Health Related Problems Associated with Obesity in Children and Adolescents?

50

References

50

5: ADHD and Oppositional Defiant Disorder (ODD)

52

5.1 Objectives

52

5.2 The Case

52

5.2.1 Owen Oland

53

5.2.2 History of Present Illness

53

5.2.2.1 Medical History

53

5.2.2.2 Family History

54

5.2.2.3 Personal and Developmental History

54

5.2.2.4 Behavior in the Office

54

5.2.2.5 Case Outcome

54

5.3 Literature Review Questions

54

5.3.1 How Was the Diagnosis of ODD Made in This Case?

54

5.3.2 Comment on the Epidemiology of ODD and the Comorbidity with ADHD?

55

5.3.3 What Is the Natural Course of ODD?

55

5.3.4 Give Examples of Tools That Can be Used to Identify ADHD, Oppositional Defiant Disorder, and Other Behavioral Disorders?

55

5.3.5 Mention Some of the Risk Factors Associated with ODD and ADHD?

56

5.3.6 What Are the General Treatment Recommendations for ODD?

57

5.3.7 What Are the Psychosocial Management Recommendations for ODD?

57

5.3.8 What Are the Treatment Considerations in Comorbid ADHD and ODD?

58

5.3.8.1 For ADHD with Behavioural Problems

58

5.3.8.2 For Treatment of Aggression

58

5.3.9 List Some of the Parent Training Programs That Are Supported by Randomized Controlled Trials?

58

References

59

6: ADHD and Conduct Disorder (CD)

61

6.1 Objectives

61

6.2 The Case

61

6.3 Alex Alexander

62

6.3.1 Identifying Information

62

6.3.2 Charges Related to the Incident

62

6.3.3 History of Present Illness

62

6.3.3.1 Substance Use

63

6.3.3.2 Mood Symptoms

63

6.3.3.3 Anxiety Symptoms

63

6.3.4 Medical History

64

6.3.4.1 Past Psychiatric History

64

6.3.4.2 Family History

64

6.3.5 Personal and Developmental History

65

6.3.5.1 Interpersonal Relationships

65

6.3.5.2 School Information

65

6.3.5.3 Mental Status Examination

66

6.3.5.4 Impression

66

6.4 Literature Review Questions

66

6.4.1 How Was the Diagnosis of Conduct Disorder Made in This Case?

66

6.4.2 Describe Some of the Findings of Epidemiological Studies of Conduct Disorder?

67

6.4.3 What Are Some of the Risk Factors for Developing Conduct Disorder?

67

6.4.4 List Some of the Instruments Measuring Externalizing Mental Health Problems in Young People?

67

6.4.5 What Are the Associated Features of Early Versus Late Onset Conduct Disorder?

69

6.4.6 List Some Psychiatric Disorders That Can Be Included in the Differential Diagnosis of Conduct Disorder?

70

6.4.7 What Are Some of the Factors Predicting Poor Outcome in Conduct Disorder?

70

6.4.8 What Are the Comorbidity Rates of ADHD and Conduct Disorder (CD)?

70

6.4.9 What Are Some of the Research Findings on Long-Term Outcomes of ADHD and Conduct Disorder?

70

6.4.10 What Are the Selective Prevention Interventions for at Risk Children and Adolescents That May Reduce the Likelihood of Developing a Conduct Disorder?

71

6.4.11 What Are the Psychosocial and Pharmacological Treatment Recommendations for Conduct Disorder and ADHD?

71

6.4.11.1 Psychosocial Interventions

71

6.4.11.2 Pharmacological Treatment

72

References

72

7: ADHD and Substance Abuse in Children and Adolescents

74

7.1 Objectives

74

7.2 The Case

74

7.3 Substance Use Literature Review Questions

76

7.3.1 Describe the Prevalence and Epidemiology of ADHD and Substance/Alcohol Use Disorder?

76

7.3.2 Explain the Possible Link Between ADHD and SUD?

77

7.3.3 Describe Some of the Challenges in the Diagnostic Assessment of ADHD and SUD?

77

7.3.4 What Psychiatric Disorders Should Be Considered and Included in the Differential Diagnosis When Assessing Individuals with Substance Use Disorders?

78

7.3.5 What Are Some of the Barriers to Seeking Addiction Treatment?

78

7.3.6 What Models of Care Are Used to Treat Concurrent Disorders in Patients with Substance Abuse? What Are the Strengths and Weaknesses of These Models?

79

7.3.7 Suggest a Screening Tool for Adolescent Substance/Alcohol Use Disorder?

80

7.3.8 What Are the National Institute of Drug Abuse Principals of Treatment of Substance Use Disorders in Adolescents?

80

7.3.9 Describe Some on the Controversial Management Considerations That Clinicians Face When Using ADHD Medications in Individuals with ADHD and Addictions?

81

7.3.10 Describe Some of the Factors That Help Make the Decision of How Long to Wait for SUD to Be Under Control Before Initiating Pharmacological Treatment of ADHD

82

7.3.11 Is There an Association Between Stimulant Medication and Substance Use Disorder?

82

7.3.12 What Are the Unique Needs of Adolescents with Substance Use Disorders?

83

7.3.13 What Are the Treatment Recommendations for Substance Abusing Patients with ADHD?

83

7.3.14 Suggest Some Web Resources for Adolescents with Substance Use Disorder?

84

7.3.15 Describe Some of the Concepts Related to Stimulant Medications Abuse and Misuse?

84

7.3.16 What Is the Rate of Stimulants Misuse or Abuse in Young People?

85

7.3.17 What Are the Correlates of Diversion and Misuse?

85

7.3.18 Describe Some of the Research Findings on Stimulant Medications Diversion?

85

7.3.19 What Are the Reasons of Abuse or Misuse of Stimulant Medications?

86

7.3.20 What Are the Clinical Implications of Stimulants Abuse or Diversion?

86

References

86

8: ADHD and Specific Learning Disorders

89

8.1 Objectives

89

8.2 Case Vignette

89

8.3 Review Questions

90

8.3.1 What Are the Rates of Comorbidities Between ADHD and Specific Learning Disorders?

90

8.3.2 Discuss the Possible Risk Factors of ADHD and Specific Learning Disorders?

90

8.3.3 Discuss the Complexity in the Assessment and Diagnosis of SLD?

91

8.3.4 What Are the Management Approaches of ADHD and SLD?

93

8.3.5 Example of Worksheets That Are Used in Schools to Check and Document That Appropriate Instruction in Reading Are Provided

94

8.3.5.1 Reading Worksheet

94

8.3.6 Example of Worksheets That Are Used in Schools to Check and Document That Appropriate Instruction in Mathematics Are Provided

95

8.3.6.1 Mathematics Worksheet

95

8.3.7 Example of Worksheets That Are Used in Schools to Check and Document That Appropriate Instruction in Written Expression Are Provided

96

8.3.7.1 Written Expression Worksheet

96

8.3.8 List Some Helpful Websites That Could Be Used to Educate Parents on Specific Learning Disorders?

98

References

98

9: ADHD and Depression

100

9.1 Objectives

100

9.2 What Are the Prevalence and Morbidity of ADHD and Depression?

100

9.3 What Are Some of the Findings of the Epidemiological Data on ADHD and Suicide?

101

9.4 What Is the Relationship Between ADHD and Suicide?

101

9.5 What Are the Possible Explanations of the Increased Suicide Risk in Patients with ADHD?

101

9.5.1 Comorbid Disorders

101

9.5.2 Cognitive Impairment and Personality Traits

102

9.5.3 Neurobiology

102

9.6 What Are Some of the Challenges in Diagnosis of ADHD in Presence of Depression or Vice Versa?

103

9.7 What Are the Management Approaches of ADHD and Depression?

103

9.8 What Is the Relationship Between ADHD Medication and Suicide?

104

9.8.1 Atomoxetine

104

9.8.2 Stimulant Medications

104

9.9 What Do I Tell Patients and Families When Asked About Suicide and ADHD Medication?

104

9.10 Give Examples of Questions That Can Be Asked to Screen for Suicide?

105

9.11 How Should I Manage Suicidal Thoughts/Behaviour During Treatment with ADHD Medications?

105

References on Depression and Suicide

106

10: ADHD and Bipolar Disorder

109

10.1 Objectives

109

10.2 Questions

109

10.2.1 What Is the Prevalence Rate of ADHD Versus Bipolar Disorder in Late Adolescence?

109

10.2.2 What Are Some of the Challenges in Differentiating Bipolar Disorder from ADHD?

110

10.2.3 List Some of the Medical Conditions That Imitate Bipolar Disorder?

110

10.2.4 What Are the Clinical Features That May Help in Clarifying the Diagnosis of ADHD and Bipolar Disorder?

110

10.2.5 What Are the Management Approaches to Comorbid Bipolar Disorder and ADHD in Late Adolescence?

112

10.2.5.1 Pharmacological Treatment

112

10.2.5.2 Psychosocial Treatment

113

References

113

Bipolar Disorders

113

Bibliography

114

Other Suggested Readings

115

11: ADHD and Tic Disorders

118

11.1 Objectives

118

11.2 Describe the Prevalence and Morbidity of TS and ADHD?

118

11.3 Give Examples of Simple and Complex Tics?

119

11.4 Give Example of Rating Scales Used in Diagnosis or Follow Up in Patients with Tics or TS?

119

11.5 What Disorders Would You Include in the Differential Diagnosis of Motor and Vocal Tics?

120

11.6 What Are the Considerations That Are Taken into Account When Clinicians Decide to Treat Tics?

120

11.7 What Are the Principals of Management of TS, Tics and When Comorbid with ADHD?

120

11.8 Describe Some of the Nonpharmacological Treatment for Tics?

121

11.8.1 Habit-Reversal Therapy (HRT)

121

11.8.2 Comprehensive Behavioural Intervention for Tics (CBIT)

122

11.8.3 Exposure and Response Prevention (ERP)

122

11.9 Describe Some of the Pharmacological Treatments for Tics?

122

11.9.1 Alpha-Adrenergic Agonists

122

11.9.2 Neuroleptics

122

11.9.3 Other Pharmacological Treatments

123

References

123

Bibliography

124

Appendices

125

Appendix A: How to Diagnose ADHD in Children and Adolescents

125

Appendix B: List of Scales: Children

127

Other Tests

128

Appendix C: Sadek ADHD Checklist (SAC) ©

130

Appendix D: Key Diagnostic Symptoms of ADHD

132

Inattentive Symptoms

132

Hyperactivity or Impulsivity Symptoms

132

Appendix E: ADHD Differential Diagnosis

133

Appendix F: Monitoring of Children and Adolescents with ADHD

135

Appendix G: ADHD Medications

136

Appendix H: Management of Adverse Events of ADHD Medications

138

Management of Side Effects

138

Common Side Effects and Contraindications: Atomoxetine

142

Appendix I: ADHD Medication Contraindications and Drug Interactions

142

Contraindications to Stimulants

142

Contraindications to Atomoxetine (Strattera)

143

Contraindications to Guanfacine XR (Intuniv XR)

143

Main Potential Drug Interactions for Psychostimulants

143

Main Potential Drug Interactions for Atomoxetine (Strattera)

143

Main Potential Drug Interactions for Guanfacine XR (Intuniv XR)

143

Appendix J: Selective Serotonin Reuptake Inhibitors (SSRIs) Dosing for Children and Adolescents

145

Appendix K: Assessment Measures Available in Public Domain Free of Charge

146

Depression and Bipolar Disorders

146

Center for Epidemiological Studies Depression Scale for Children (CES-DC)

146

Depression Self-Rating Scale for Children (DSRS)

146

Patient Health Questionnaire-9 (PHQ-9)

146

Child Mania Rating Scale-Parent Version (CMRS-P) New!

146

Anxiety

146

Self-Report for Childhood Anxiety Related Disorders (SCARED)

146

Revised Children’s Anxiety and Depression Scale (RCADS)

147

Spence Children’s Anxiety Scale (SCAS)

147

Penn State Worry Questionnaire for Children (PSWQ-C) New!

147

Generalized Anxiety Disorder-7 (GAD-7)

147

Appendix L: Helpful Websites

148